DUBLIN–(BUSINESS WIRE)–The “Home Diagnostics Markets. Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides. “ report has been added to ResearchAndMarkets.com’s offering.
Covid-19 awakens the sleeping giant of at-home diagnostics. Home Diagnostics are set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
The report includes five-year market forecasts.
Make investment decisions and valuations with confidence using the latest data.
Home Diagnostics Recent Developments
- Startup Detect Roll Next-Gen Molecular Instrument
- Diagnostics of the Real World Third-Generation Platform
- Labcorp Partnering With Getlabs Home Collection
- Salignostics Closes Funding Round
- Health Targets Market 2022
- Grip Molecular Developing Home Respiratory Panel
- Mainz Biomed Developing Home ColoAlert Assay
- Fertility Closes Series A Financing Round
- Continued Demand SARS-CoV-2 Rapid Tests
- Rapid Covid-19 Test Results Risk Going Uncounted
- Grants EUAs Direct-to-Consumer Coronavirus
- Researchers Develop 15-Minute System
- Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
- Lucira Health Files $115M
- Spectrum Solutions Gets Mark Saliva Collection Devices
- Sherlock Biosciences Receives Gates Foundation Grant COVID-19 Self-Test
- LabCorp Receives for COVID-19 Test Home Collection
- FemtoDx Launches Rapid At-Home Test Development COVID-19
- approves first at-home coronavirus test
- Free Home Tests Detect More Infections
- Biohacking trend supports self testing
- PerkinElmer EverlyWell Expand U.S. At-Home Health Test Market
- Mylan, Atomo Diagnostics WHO Prequalification Approval HIV Self-Test
- OraSure Technologies, Inc. Announces Acquisitions
- Nigerian Govt Approves Alere Self-Test
- Boots launches test treat service across branches
- Scanwell Health moves beyond home testing
- Healthy.io raises million at-home urinalysis tests
- LetsGetChecked collects $30M more at-home health testing
- TestCard, a Urine Test Read Smartphone
- Digital Health Startup EverlyWell Raises $50M
- Thriva adds test-at-home kits for female hormone cortisol stress
- Tasso scores $6.1M patch-based home blood testing
- Systems HEMAXIS receives CE/IVD mark
- Abbott HbA1c point-of-care test reliably diagnoses diabetes
Industry Overview
Industry Participants
- Supplier
- Independent specialized/esoteric
- Independent national/regional
- Independent analytical
- Public National/regional
- Hospital
- Physician
- Pharmacies
- Audit body
Diagnostic Market Segments
- Traditional Market Segmentation
- Laboratory Focus Segmentation
- Segmenting Home Diagnostics Market
Industry Structure
- Hospital Testing Share
- Economies Scale
- Hospital Central
- Physician Office Lab’s
- Problem with POLS
- Physician’s Home Diagnostics
- Pharmacies Home Diagnostics
- Diagnostic Plight Pharmacies – Trying good
- Theranos Legacy
Market Trends
Factors Driving Growth
- Privacy Anonymity
- Internet Effect
- Rapid Result
- Wellness Movement
- COVID-19 Impact
Factors Limiting Growth
- Trust Factor
- Infectious Disease Declining But..
- Wellness Hurts
- Economic Growth improves Living Standards
Diagnostic Technology Development
- Multiplex Paradigm Shift
- vs. Lateral Flow
- Unusual Role
- Self Send Competition
- Relationship Genetic
- Relationship TeleHealth
- Sample Collection – Knew?
Profiles Home Diagnostics Companies
- 1DropDiagnostics
- Abbott Diagnostics
- Ador Diagnostics
- Biotech
- Akonni Biosystems
- Alveo Technologies
- Applied BioCode
- Atomo Diagnostics
- Diagnostics
- Becton, Dickinson Company
- Binx Health
- Biocartis
- BioFire Diagnostics (bioMerieux)
- bioMerieux Diagnostics
- Bio-Rad Laboratories, Inc
- Bosch Healthcare Solutions GmbH
- Cepheid (Danaher)
- Health
- Curetis N.V./Curetis GmbH
- Systems
- Detect
- Diagenode Diagnostics
- Diasorin S.p.A.
- Ellume
- Everywell
- Getlabs
- Grip Molecular Technologies
- Healthy.io
- Hologic
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Laboratory Corporation America.
- Letsgetchecked
- Lexagene
- Lucira Health
- Luminex Corp
- Mbio Diagnostics
- Mesa Biotech (Thermo Fisher)
- Fertility
- Mobidiag (Hologic)
- myLabBox
- Mylan
- Nanomix
- OraSure Technologies
- Oxford Nanopore Technologies
- Panagene
- Primerdesign (Novacyt)
- Prominex
- Qiagen
- QuantuMDx
- Quest Diagnostics
- Quidel
- Randox Toxicology
- Roche Molecular Diagnostics
- Salignostics
- Scanwell Health
- Biosensor
- Seegene
- Seventh Sense Biosystems
- Siemens Healthineers
- Biosystems
- TestCard
- Thermo Fisher Scientific Inc.
- Thriva
- Visby Medical
- XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/oi0hrw
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
